Harnessing monocyte-derived macrophages to control central nervous system pathologies: No longer if' but how'

Journal of Pathology

Volumn 229, Issue 2, 2013, Pages 332-346

  Shechter, Ravid ^a   Schwartz, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

CNS pathology; macrophages; microglia; monocytes; neurodegenerative disease; neuroimmunology; spinal cord injury

Indexed keywords

ALZHEIMER DISEASE; ANGIOGENESIS; AUTOIMMUNE DISEASE; CELL RENEWAL; CELL TYPE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM PATHOLOGY; DEGENERATIVE DISEASE; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MENTAL DISEASE; MICROGLIA; MONOCYTE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS TISSUE; NONHUMAN; OUTCOME ASSESSMENT; PATHOLOGY; PHAGOCYTE; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; REMYELINIZATION; REVIEW; TISSUE REGENERATION; TRAUMATIC BRAIN INJURY;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MENTAL DISORDERS; MICROGLIA; NEURODEGENERATIVE DISEASES; PHENOTYPE;

EID: 84871060866     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4106     Document Type: Review

References (144)

1. Medawar PB,. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948; 29: 58-69.
2. Boster A, Edan G, Frohman E, et al,. Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician. Lancet Neurol 2008; 7: 173-183.
3. Bracken MB, Shepard MJ, Collins WF, et al,. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322: 1405-1411. (Pubitemid 20152525)
4. McGeer PL, McGeer E, Rogers J, et al,. Anti-inflammatory drugs and Alzheimer disease. Lancet 1990; 335: 1037. (Pubitemid 20148621)
5. David S, Kroner A,. Repertoire of microglial and macrophage responses after spinal cord injury. Nature Rev Neurosci 2011; 12: 388-399.
6. Prinz M, Priller J, Sisodia SS, et al,. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nature Neurosci 2011; 14: 1227-1235.
7. Ransohoff RM, Cardona AE,. The myeloid cells of the central nervous system parenchyma. Nature 2010; 468: 253-262.
8. Saijo K, Glass CK,. Microglial cell origin and phenotypes in health and disease. Nature Rev Immunol 2011; 11: 775-787.
9. Graeber MB,. Changing face of microglia. Science 2010; 330: 783-788.
10. Rivest S,. Regulation of innate immune responses in the brain. Nature Rev Immunol 2009; 9: 429-439.
11. Ransohoff RM, Perry VH,. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009; 27: 119-145.
12. Hanisch UK, Kettenmann H,. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature Neurosci 2007; 10: 1387-1394. (Pubitemid 350014685)
13. Vargas ME, Barres BA,. Why is Wallerian degeneration in the CNS so slow? Annu Rev Neurosci 2007; 30: 153-179. (Pubitemid 47218754)
14. Ginhoux F, Greter M, Leboeuf M, et al,. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010; 330: 841-845.
15. Mallat M, Chamak B,. Brain macrophages: neurotoxic or neurotrophic effector cells? J Leukoc Biol 1994; 56: 416-422. (Pubitemid 24295815)
16. Rapalino O, Lazarov-Spiegler O, Agranov E, et al,. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nature Med 1998; 4: 814-821. (Pubitemid 28331023)
17. Schwartz M, Yoles E,. Immune-based therapy for spinal cord repair: autologous macrophages and beyond. J Neurotrauma 2006; 23: 360-370. (Pubitemid 43739276)
18. Simard AR, Soulet D, Gowing G, et al,. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006; 49: 489-502. (Pubitemid 43221886)
19. Shechter R, London A, Varol C, et al,. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 2009; 6: e1000113.
20. Derecki NC, Cronk JC, Lu Z, et al,. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 2012; 484: 105-109.
21. Schwartz M, Shechter R,. Systemic inflammatory cells fight off neurodegenerative disease. Nature Rev Neurol 2010; 6: 405-410.
22. Gordon S, Taylor PR,. Monocyte and macrophage heterogeneity. Nature Rev Immunol 2005; 5: 953-964. (Pubitemid 41746764)
23. Gordon S, Martinez FO,. Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32: 593-604.
24. Mosser DM, Edwards JP,. Exploring the full spectrum of macrophage activation. Nature Rev Immunol 2008; 8: 958-969.
25. Pollard JW,. Trophic macrophages in development and disease. Nature Rev Immunol 2009; 9: 259-270.
26. Biswas SK, Mantovani A,. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature Immunol 2010; 11: 889-896.
27. Qian BZ, Pollard JW,. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141: 39-51.
28. Popovich PG, Longbrake EE,. Can the immune system be harnessed to repair the CNS? Nature Rev Neurosci 2008; 9: 481-493. (Pubitemid 351704948)
29. Young W,. Methylprednisolone and spinal cord injury. J Neurosurg 2002; 96: 141-142.
30. Bracken MB, Shepard MJ, Holford TR, et al,. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998; 89: 699-706. (Pubitemid 28485526)
31. Editorial. Steroids after spinal cord injury. Lancet 1990; 336: 279-280.
32. Letellier E, Kumar S, Sancho-Martinez I, et al,. CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity 2010; 32: 240-252.
33. Wells JE, Hurlbert RJ, Fehlings MG, et al,. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 2003; 126: 1628-1637. (Pubitemid 36834939)
34. Sanchez Mejia RO, Ona VO, Li M, et al,. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001; 48: 1393- 1399; discussion 1399- 1401.
35. Arvin KL, Han BH, Du Y, et al,. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 2002; 52: 54-61. (Pubitemid 34693743)
36. Popovich PG, Guan Z, Wei P, et al,. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 1999; 158: 351-365. (Pubitemid 29382826)
37. Knoller N, Auerbach G, Fulga V, et al,. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J Neurosurg Spine 2005; 3: 173-181.
38. Lammertse DP, Jones LA, Charlifue SB, et al,. Autologous incubated macrophage therapy in acute, complete spinal cord injury: results of the phase 2 randomized controlled multicenter trial. Spinal Cord 2012; 50: 661-671.
39. Yoon SH, Shim YS, Park YH, et al,. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial. Stem Cells 2007; 25: 2066-2073.
40. Kumar AA, Kumar SR, Narayanan R, et al,. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I/II clinical safety and primary efficacy data. Exp Clin Transplant 2009; 7: 241-248.
41. Yin Y, Henzl MT, Lorber B, et al,. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nature Neurosci 2006; 9: 843-852.
42. London A, Itskovich E, Benhar I, et al,. Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J Exp Med 2011; 208: 23-39.
43. Davalos D, Grutzendler J, Yang G, et al,. ATP mediates rapid microglial response to local brain injury in vivo. Nature Neurosci 2005; 8: 752-758. (Pubitemid 43085841)
44. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, et al,. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 2007; 446: 1091-1095. (Pubitemid 46676051)
45. Coull JA, Beggs S, Boudreau D, et al,. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005; 438: 1017-1021. (Pubitemid 43093974)
46. Rolls A, Shechter R, London A, et al,. Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med 2008; 5: e171.
47. Popovich PG, Hickey WF,. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J Neuropathol Exp Neurol 2001; 60: 676-685. (Pubitemid 32619790)
48. Fry EJ, Ho C, David S,. A role for Nogo receptor in macrophage clearance from injured peripheral nerve. Neuron 2007; 53: 649-662. (Pubitemid 46283376)
49. Zhu Z, Ni B, Yin G, et al,. NgR expression in macrophages promotes nerve regeneration after spinal cord injury in rats. Arch Orthop Trauma Surg 2010; 130: 945-951.
50. Shechter R, Raposo C, London A, et al,. The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair. PLoS One 2011; 6: e27969.
51. Donnelly DJ, Longbrake EE, Shawler TM, et al,. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J Neurosci 2011; 31: 9910-9922.
52. Saederup N, Cardona AE, Croft K, et al,. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One 2010; 5: e13693.
53. Cardona AE, Pioro EP, Sasse ME, et al,. Control of microglial neurotoxicity by the fractalkine receptor. Nature Neurosci 2006; 9: 917-924. (Pubitemid 43980506)
54. Kigerl KA, Gensel JC, Ankeny DP, et al,. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009; 29: 13435-13444.
55. Zhang Z, Zhang ZY, Wu Y, et al,. Lesional accumulation of CD163(+) macrophages/microglia in rat traumatic brain injury. Brain Res 2012; 1461: 102-110.
56. Ziv Y, Avidan H, Pluchino S, et al,. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci U S A 2006; 103: 13174-13179. (Pubitemid 44338935)
57. Dougherty KD, Dreyfus CF, Black IB,. Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiol Dis 2000; 7: 574-585. (Pubitemid 32044283)
58. Barrette B, Hebert MA, Filali M, et al,. Requirement of myeloid cells for axon regeneration. J Neurosci 2008; 28: 9363-9376.
59. Glod J, Kobiler D, Noel M, et al,. Monocytes form a vascular barrier and participate in vessel repair after brain injury. Blood 2006; 107: 940-946. (Pubitemid 43156290)
60. Schonberg DL, Goldstein EZ, Sahinkaya FR, et al,. Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo. J Neurosci 2012; 32: 5374-5384.
61. Butovsky O, Koronyo-Hamaoui M, Kunis G, et al,. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci U S A 2006; 103: 11784-11789. (Pubitemid 44182528)
62. Beers DR, Henkel JS, Xiao Q, et al,. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2006; 103: 16021-16026. (Pubitemid 44657585)
63. Appel SH, Beers DR, Henkel JS,. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? Trends Immunol 2010; 31: 7-17.
64. Beduneau A, Ma Z, Grotepas CB, et al,. Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles. PLoS One 2009; 4: e4343.
65. Persidsky Y, Zheng J, Miller D, et al,. Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 2000; 68: 413-422.
66. Wyss-Coray T,. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nature Med 2006; 12: 1005-1015. (Pubitemid 44353380)
67. Wisniewski HM, Wegiel J, Wang KC, et al,. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can J Neurol Sci 1989; 16: 535-542. (Pubitemid 19278365)
68. Akiyama H, Arai T, Kondo H, et al,. Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis Assoc Disord 2000; 14 (Suppl 1): S47 - S53. (Pubitemid 30406772)
69. Frackowiak J, Potempska A, LeVine H, et al,. Extracellular deposits of A beta produced in cultures of Alzheimer disease brain vascular smooth muscle cells. J Neuropathol Exp Neurol 2005; 64: 82-90. (Pubitemid 40189482)
70. Fuhrmann M, Bittner T, Jung CK, et al,. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nature Neurosci 2010; 13: 411-413.
71. Grathwohl SA, Kalin RE, Bolmont T, et al,. Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nature Neurosci 2009; 12: 1361-1363.
72. Meyer-Luehmann M, Spires-Jones TL, Prada C, et al,. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008; 451: 720-724. (Pubitemid 351220570)
73. Lebson L, Nash K, Kamath S, et al,. Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice. J Neurosci 2010; 30: 9651-9658.
74. Majumdar A, Chung H, Dolios G, et al,. Degradation of fibrillar forms of Alzheimer's amyloid beta-peptide by macrophages. Neurobiol Aging 2008; 29: 707-715. (Pubitemid 351400828)
75. El Khoury J, Toft M, Hickman SE, et al,. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nature Med 2007; 13: 432-438. (Pubitemid 46559828)
76. Naert G, Rivest S,. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. J Neurosci 2011; 31: 6208-6220.
77. Janelsins MC, Mastrangelo MA, Oddo S, et al,. Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation 2005; 2: 23.
78. Shaftel SS, Carlson TJ, Olschowka JA, et al,. Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J Neurosci 2007; 27: 9301-9309. (Pubitemid 47358197)
79. Shaftel SS, Kyrkanides S, Olschowka JA, et al,. Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest 2007; 117: 1595-1604. (Pubitemid 46871344)
80. Mildner A, Schlevogt B, Kierdorf K, et al,. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J Neurosci 2011; 31: 11159-11171.
81. Hawkes CA, McLaurin J,. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A 2009; 106: 1261-1266.
82. Mucke L., Neuroscience: Alzheimer's disease. Nature 2009; 461: 895-897.
83. Butovsky O, Landa G, Kunis G, et al,. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest 2006; 116: 905-915.
84. Butovsky O, Kunis G, Koronyo-Hamaoui M, et al,. Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model. Eur J Neurosci 2007; 26: 413-416. (Pubitemid 47087602)
85. Habisch HJ, Schwalenstocker B, Danzeisen R, et al,. Limited effects of glatiramer acetate in the high-copy number hSOD1-G93A mouse model of ALS. Exp Neurol 2007; 206: 288-295. (Pubitemid 47094773)
86. Meininger V, Drory VE, Leigh PN, et al,. Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double-blind, randomized, multicentre, placebo-controlled trial. Amyotroph Lateral Scler 2009; 10: 378-383.
87. Haenggeli C, Julien JP, Mosley RL, et al,. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS. Neurobiol Dis 2007; 26: 146-152. (Pubitemid 46436494)
88. Koronyo-Hamaoui M, Ko MK, Koronyo Y, et al,. Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9. J Neurochem 2009; 111: 1409-1424.
89. Town T, Laouar Y, Pittenger C, et al,. Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nature Med 2008; 14: 681-687. (Pubitemid 351809551)
90. Chakrabarty P, Jansen-West K, Beccard A, et al,. Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J 2010; 24: 548-559.
91. Boissonneault V, Rivest S,. [ The hematopoietic cytokine M-CSF as a cure for Alzheimer's disease ]. Med Sci (Paris) 2009; 25: 666-668.
92. Shin JW, Lee JK, Lee JE, et al,. Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell-derived factor-1alpha in an Alzheimer's disease mouse model. Stem Cells 2011; 29: 1075-1089.
93. Bruck W, Sommermeier N, Bergmann M, et al,. Macrophages in multiple sclerosis. Immunobiology 1996; 195: 588-600. (Pubitemid 26361485)
94. Tran EH, Hoekstra K, van Rooijen N, et al,. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 1998; 161: 3767-3775.
95. Bartholomaus I, Kawakami N, Odoardi F, et al,. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009; 462: 94-98.
96. Wu C, Rauch U, Korpos E, et al,. Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression. J Immunol 2009; 182: 6508-6516.
97. Li H, Cuzner ML, Newcombe J,. Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol Appl Neurobiol 1996; 22: 207-215. (Pubitemid 26177449)
98. Ajami B, Bennett JL, Krieger C, et al,. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nature Neurosci 2011; 14: 1142-1149.
99. Huang DR, Wang J, Kivisakk P, et al,. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 2001; 193: 713-726.
100. Mildner A, Mack M, Schmidt H, et al,. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 2009; 132: 2487-2500.
101. King IL, Dickendesher TL, Segal BM,. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009; 113: 3190-3197.
102. Zhang Z, Zhang ZY, Schittenhelm J, et al,. Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains. J Neuroimmunol 2011; 237: 73-79.
103. Boven LA, Van Meurs M, Van Zwam M, et al,. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 2006; 129: 517-526. (Pubitemid 43164373)
104. Mikita J, Dubourdieu-Cassagno N, Deloire MS, et al,. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 2011; 17: 2-15.
105. hi inflammatory monocyte to M2 macrophages and improved outcome. J Immunol 2012; 189: 551-557.
106. Bogie JF, Stinissen P, Hellings N, et al,. Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation. J Neuroinflammation 2011; 8: 85.
107. Zhu B, Bando Y, Xiao S, et al,. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol 2007; 179: 5228-5237.
108. Youn JI, Nagaraj S, Collazo M, et al,. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008; 181: 5791-5802.
109. Zhu B, Kennedy JK, Wang Y, et al,. Plasticity of Ly-6C(hi) myeloid cells in T cell regulation. J Immunol 2011; 187: 2418-2432.
110. Li WW, Setzu A, Zhao C, et al,. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 2005; 158: 58-66. (Pubitemid 39626071)
111. Villeda SA, Luo J, Mosher KI, et al,. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011; 477: 90-94.
112. Ruckh JM, Zhao JW, Shadrach JL, et al,. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 2012; 10: 96-103.
113. Weber MS, Prod'homme T, Youssef S, et al,. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nature Med 2007; 13: 935-943. (Pubitemid 47222047)
114. Burger D, Molnarfi N, Weber MS, et al,. Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis. Proc Natl Acad Sci U S A 2009; 106: 4355-4359.
115. Vaknin I, Kunis G, Miller O, et al,. Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis. PLoS One 2011; 6: e26921.
116. Zhao C, Deng W, Gage FH,. Mechanisms and functional implications of adult neurogenesis. Cell 2008; 132: 645-660. (Pubitemid 351253687)
117. Kokaia Z, Martino G, Schwartz M, et al,. Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nature Neurosci 2012; 15: 1078-1087.
118. Martino G,. How the brain repairs itself: new therapeutic strategies in inflammatory and degenerative CNS disorders. Lancet Neurol 2004; 3: 372-378. (Pubitemid 38648859)
119. Monje ML, Toda H, Palmer TD,. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003; 302: 1760-1765. (Pubitemid 37505739)
120. Jakubs K, Bonde S, Iosif RE, et al,. Inflammation regulates functional integration of neurons born in adult brain. J Neurosci 2008; 28: 12477-12488.
121. Ekdahl CT, Claasen JH, Bonde S, et al,. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A 2003; 100: 13632-13637. (Pubitemid 37444791)
122. Walton NM, Sutter BM, Laywell ED, et al,. Microglia instruct subventricular zone neurogenesis. Glia 2006; 54: 815-825. (Pubitemid 44671987)
123. Choi SH, Veeraraghavalu K, Lazarov O, et al,. Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation. Neuron 2008; 59: 568-580.
124. Butovsky O, Ziv Y, Schwartz A, et al,. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 2006; 31: 149-160. (Pubitemid 43049908)
125. Cacci E, Ajmone-Cat MA, Anelli T, et al,. In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia. Glia 2008; 56: 412-425. (Pubitemid 351212950)
126. Ziv Y, Ron N, Butovsky O, et al,. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nature Neurosci 2006; 9: 268-275. (Pubitemid 43164551)
127. Vukovic J, Colditz MJ, Blackmore DG, et al,. Microglia modulate hippocampal neural precursor activity in response to exercise and aging. J Neurosci 2012; 32: 6435-6443.
128. Sierra A, Encinas JM, Deudero JJ, et al,. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 2010; 7: 483-495.
129. Borders AS, Hersh MA, Getchell ML, et al,. Macrophage-mediated neuroprotection and neurogenesis in the olfactory epithelium. Physiol Genomics 2007; 31: 531-543. (Pubitemid 350127792)
130. Borders AS, Getchell ML, Etscheidt JT, et al,. Macrophage depletion in the murine olfactory epithelium leads to increased neuronal death and decreased neurogenesis. J Comp Neurol 2007; 501: 206-218. (Pubitemid 46233329)
131. Ruitenberg MJ, Vukovic J, Blomster L, et al,. CX3CL1/fractalkine regulates branching and migration of monocyte-derived cells in the mouse olfactory epithelium. J Neuroimmunol 2008; 205: 80-85.
132. Derecki NC, Cardani AN, Yang CH, et al,. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 2010; 207: 1067-1080.
133. Tepavcevic V, Lazarini F, Alfaro-Cervello C, et al,. Inflammation-induced subventricular zone dysfunction leads to olfactory deficits in a targeted mouse model of multiple sclerosis. J Clin Invest 2011; 121: 4722-4734.
134. Muzio L, Cavasinni F, Marinaro C, et al,. Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis. Mol Cell Neurosci 2010; 43: 268-280.
135. Peng H, Sun L, Jia B, et al,. HIV-1-infected and immune-activated macrophages induce astrocytic differentiation of human cortical neural progenitor cells via the STAT3 pathway. PLoS One 2011; 6: e19439.
136. Imitola J, Raddassi K, Park KI, et al,. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 2004; 101: 18117-18122. (Pubitemid 40054083)
137. Yan YP, Lang BT, Vemuganti R, et al,. Persistent migration of neuroblasts from the subventricular zone to the injured striatum mediated by osteopontin following intracerebral hemorrhage. J Neurochem 2009; 109: 1624-1635.
138. Yang J, Jiang Z, Fitzgerald DC, et al,. Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis. J Clin Invest 2009; 119: 3678-3691.
139. Martino G, Pluchino S,. The therapeutic potential of neural stem cells. Nature Rev Neurosci 2006; 7: 395-406.
140. Cusimano M, Biziato D, Brambilla E, et al,. Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord. Brain 2012; 135: 447-460.
141. Rolls A, Shechter R, London A, et al,. Toll-like receptors modulate adult hippocampal neurogenesis. Nature Cell Biol 2007; 9: 1081-1088. (Pubitemid 47338146)
142. Shechter R, Ronen A, Rolls A, et al,. Toll-like receptor 4 restricts retinal progenitor cell proliferation. J Cell Biol 2008; 183: 393-400.
143. Condeelis J, Pollard JW,. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124: 263-266. (Pubitemid 43121975)
144. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)